Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Development-stage index

Phase 2Peptide Trials.

Explore every Phase 2 peptide study in the local registry snapshot. Compare recruitment, sponsors, therapeutic areas, enrollment, results, publications and study geography.

Studies
709
Recruiting
135
Completed
350
Results posted
229
Countries
67
Avg enrollment
125

Velocity

Phase 2 trials by start year

Study start year · indexed snapshot

71533618019971997: 1 trials1998: 0 trials1999: 1 trials2000: 1 trials2001: 9 trials2002: 7 trials20032003: 9 trials2004: 9 trials2005: 11 trials2006: 31 trials2007: 15 trials2008: 11 trials20092009: 13 trials2010: 15 trials2011: 25 trials2012: 27 trials2013: 20 trials2014: 20 trials20152015: 27 trials2016: 35 trials2017: 28 trials2018: 32 trials2019: 31 trials2020: 30 trials20212021: 43 trials2022: 29 trials2023: 40 trials2024: 54 trials2025: 62 trials2026: 71 trials20272027: 2 trials

Development

Trials by phase

Early Phase 10
Phase 177
Phase 2709
Phase 354
Phase 40

Industry

Leading sponsors

AstraZeneca16
Eli Lilly14
Stealth BioTherapeutics Inc.14
Novartis13
Novo Nordisk11
BioMarin9
Ipsen9
Rhythm Pharmaceuticals, Inc.9

Therapeutic areas

Condition groups

Weight loss87
Type 2 diabetes36
Brain health24
Pain21
Inflammation15
Longevity11
Crohn's3
Hair loss1

Compound leaders

Most represented peptides.

01Leuprolide4302Degarelix4103Goserelin4004Pasireotide3805Thymosin Alpha-13106Triptorelin3107Octreotide2408Tirzepatide2409Glucagon2310Lanreotide2311Metreleptin2312Oxytocin21

Study explorer

Search this collection.

709 matching studies